市場調査レポート
商品コード
1327318

医療用放射線遮蔽の世界市場:製品別、ソリューション別、エンドユーザー別、地域別-2028年までの予測

Medical Radiation Shielding Market by Products, Solution, End-user, & Region - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 195 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
医療用放射線遮蔽の世界市場:製品別、ソリューション別、エンドユーザー別、地域別-2028年までの予測
出版日: 2023年08月03日
発行: MarketsandMarkets
ページ情報: 英文 195 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

医療用放射線遮蔽の市場規模は、予測期間中のCAGRが6.5%となり、2023年の14億米ドルから2028年には18億米ドルに達すると予測されています。

MRI遮蔽製品の成長は、電離放射線への曝露に伴う潜在的な健康リスクに対する認識が、放射線を受けやすい環境で働く人々の間で急速に高まっていることが主な要因です。カナダ保健省、米国放射線防護測定審議会(NCRP)、オーストラリア放射線防護原子力安全庁(ARPANSA)など、さまざまな政府機関や民間団体が放射線遮蔽製品に関するガイドラインやプロトコルを取り入れています。こうした取り組みにより、専門家の安全意識が高まり、放射線防護システムの導入が促進されています。また、調査やシンポジウムはこの分野の研究を紹介し、業界のリーダーたちにこの分野の研究開発に力を入れています。

診断用遮蔽は同市場において最も高い成長が見込まれており、その要因としては、癌のような様々な慢性疾患の有病率が上昇していることが挙げられます。癌研究に対する官民投資の増加が診断用遮蔽市場の成長を支えています。

世界の医療用放射線遮蔽市場において、北米は、訓練を受けた放射線技師の数が増加しているため、予測期間中に高い市場シェアが見込まれます。労働統計局によると、2020年には米国で254,000人の放射線技師の雇用が見込まれています。また、労働統計局は、米国における放射線技師とMRI技師の雇用は、2020年から2030年にかけて9%の割合で成長すると予測しています。

当レポートでは、世界の医療用放射線遮蔽市場について調査し、製品別、ソリューション別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 主要な利害関係者と購入基準
  • 規制状況
  • 貿易分析
  • エコシステム分析
  • 特許分析
  • 2023年~2024年の主な会議とイベント
  • 価格分析
  • 顧客のビジネスに影響を与える動向/混乱
  • 技術分析

第6章 医療用放射線遮蔽市場、製品別

  • イントロダクション
  • MRIシールド製品
  • 鉛入りガラス、ドア、窓
  • 鉛入り乾式壁と合板
  • シールド、バリア、ブース
  • 鉛シート
  • 鉛ブロック
  • 高密度コンクリートブロック
  • X線室
  • リードカーテンとスクリーン
  • 鉛アクリル

第7章 医療用放射線遮蔽市場、ソリューション別

  • イントロダクション
  • 放射線療法の遮蔽
  • 診断用遮蔽

第8章 医療用放射線遮蔽市場、エンドユーザー別

  • イントロダクション
  • 病院、ASCS、クリニック
  • 診断センター

第9章 医療用放射線遮蔽市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 概要
  • 市場ランキング
  • 主要企業のための企業評価クアドラント
  • 中小企業/新興企業向けの企業評価クアドラント
  • 競合ベンチマーキング
  • 企業フットプリント分析
  • 競合シナリオ

第11章 企業プロファイル

  • 主要参入企業
    • ETS-LINDGREN(AN ESCO TECHNOLOGIES COMPANY)
    • BIODEX(A PART OF MIRION TECHNOLOGIES, INC.)
    • NELCO WORLDWIDE
    • GAVEN INDUSTRIES, INC.
    • RADIATION PROTECTION PRODUCTS, INC.
    • MARSHIELD(A DIVISION OF MARS METAL CO.)
    • RAY-BAR ENGINEERING CORP.
    • AMRAY MEDICAL
    • A&L SHIELDING
    • GLOBAL PARTNERS IN SHIELDING, INC.
    • VERITAS MEDICAL SOLUTIONS LLC
    • ALIMED, INC.
    • PROTECH MEDICAL
    • GLOBE COMPOSITE SOLUTIONS LLC
    • ULTRARAY
    • MARS METAL COMPANY
    • NUCLEAR LEAD CO.
    • NUCLEAR SHIELDS B.V.
  • その他の企業
    • SHIELDING INTERNATIONAL INC.
    • BAR-RAY PRODUCTS, INC.
    • XENA SHIELD
    • BURLINGTON MEDICAL
    • SIMAD SRL
    • EUROPEAN EMC PRODUCTS

第12章 付録

目次
Product Code: MD 4508

The medical radiation shielding market is projected to reach USD 1.8 Billion by 2028 from USD 1.4 Billion in 2023, at a CAGR of 6.5% during the forecast period. Growth in MRI shielding products is mainly driven by the Awareness of the potential health risks associated with exposure to ionizing radiation is increasing rapidly among people working in radiation-prone environments. Various government and private organizations, such as Health Canada, the National Council on Radiation Protection & Measurements (NCRP), and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), have incorporated guidelines and protocols regarding radiation shielding products. These initiatives increase safety awareness among professionals and encourage the adoption of radiation protection systems. Conferences and symposia also showcase research in this field and make industry leaders aware of the developments in this sector.

"The Diagnostic Shielding segment accounted for the highest market share in the medical radiation shielding solution market, by type, during the forecast period."

Based on the solution of the segment, the medical radiation shielding market is categorized as Diagnostic Shielding and Radiation Therapy Shielding. Diagnostic Shielding is expected to have the highest growth in the market, which is attributed to the rising prevalence of various chronic diseases like cancer, which is attributed to the Increasing public-private investments in cancer research, id supporting the growth of the Diagnostic Shielding market.

"The North America segment accounted for the highest market share in the medical radiation shielding market, by region, during the forecast period."

Based on the region, the global medical radiation shielding market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness a high market share during the forecast period due to the Increasing number of trained radiologic technologists. According to the Bureau of Labor Statistics, in 2020, ~254,000 radiologic technologists' jobs were expected to be available in the US. The Bureau of Labor Statistics has also estimated that the employment of radiologic and MRI technologists is expected to grow at a rate of 9% from 2020 to 2030 in the US.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
  • By Designation: C-level (40%), Director-level (26%), and Others (34%)
  • By Region: North America (35%), Europe (30%), Asia- Pacific (21%), RoW- (14%),

Prominent companies include ESCO Technologies (US), Mirion Technology (US), Nelco Worldwide (US), Gaven Industries Inc. (US), Radiation Protection Products, Inc. (US), Marshield (Canada), Ray-Bar Engineering Corp. (US), Amray Medical (Ireland), A&L Shielding (US), Global Partners in Shielding Inc. (US), Veritas Medical Solutions LLC. (US), AliMed Inc. (US), Protech Medical (US), Ultraray (US), Mars Metal Company (Canada), Nuclear Lead Co. Inc. (US), Nuclear Shields B.V. (Netherlands), Globe Composite Solutions LLC. (US), Shielding International Inc. (US), Bar-Ray Products (US), Xena Shield (India), Burlington Medical (US), SIMAD S.r.l. (Italy) and European EMC Products (UK).

Research Coverage

This research report categorizes the medical radiation shielding market by product (MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheet, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic), By Solution (Diagnostic Shielding and Radiation Therapy Shielding), Diagnostic Shielding segment (X-ray, MRI, CT scanners and Nuclear Imaging) and Radiation Therapy Shielding segment (Linear Accelerator, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy), by end-user (Hospitals, Clinics and Ambulatory Surgery Centers and Diagnostic Centers), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the medical radiation shielding market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the medical radiation shielding market. Competitive analysis of upcoming startups in the medical radiation shielding market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical radiation shielding market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, Growing incidences of cancer, Increasing safety awareness among people working in radiation-prone environments, Growth in the number of PET/CT scans, and Increasing number of trained radiologic technologists,), restraints (Lack of adequate healthcare infrastructure and Dearth Of Skilled Oncologist/Radiologist) opportunities (Rising healthcare expenditure across developing countries, Increasing public-private investments in cancer research, Growing government and private investments to meet the increasing demand for cancer treatment, Technological advancements in radiation detection and Increasing usage of nuclear medicine & radiation therapy coupled with the rising incidence of cancer) and Challenges (High cost of lead in manufacturing radiation accessories) are influencing the growth of the radiation shielding market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical radiation shielding market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the medical radiation shielding market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical radiation shielding market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the medical radiation shielding market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 MEDICAL RADIATION SHIELDING MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 INDICATORS AND ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT
  • 2.8 IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 9 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET

4 PREMIUM INSIGHTS

  • 4.1 MEDICAL RADIATION SHIELDING MARKET OVERVIEW
    • FIGURE 15 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 2022
    • FIGURE 16 DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
  • 4.3 MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT
    • FIGURE 17 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment
      • 5.2.1.2 Growing incidence of cancer
    • TABLE 2 NUMBER OF NEW CANCER CASES, 2020-2040
    • TABLE 3 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
      • 5.2.1.3 Increasing safety awareness among people working in radiation-prone environments
      • 5.2.1.4 Growth in number of PET/CT scans
    • TABLE 4 CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)
    • TABLE 5 CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)
      • 5.2.1.5 Increasing number of trained radiologic technologists
    • TABLE 6 METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of adequate healthcare infrastructure
      • 5.2.2.2 Shortage of skilled oncologists/radiologists
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising healthcare expenditure across developing countries
      • 5.2.3.2 Increasing public-private investments in cancer research
      • 5.2.3.3 Technological advancements in radiation detection
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High cost of lead in manufacturing radiation accessories
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 THREAT OF SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 BARGAINING POWER OF SUPPLIERS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
    • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
    • 5.6.2 BUYING CRITERIA
    • FIGURE 22 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
    • TABLE 8 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 NORTH AMERICA
    • 5.7.2 EUROPE
    • 5.7.3 ASIA PACIFIC
  • 5.8 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 10 EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.9 ECOSYSTEM ANALYSIS
    • FIGURE 23 KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET
    • TABLE 11 ROLE IN ECOSYSTEM
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 12 LIST OF CONFERENCES & EVENTS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
    • TABLE 13 PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD)
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 TECHNOLOGY ANALYSIS

6 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 14 MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 MRI SHIELDING PRODUCTS
    • 6.2.1 INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET
    • TABLE 15 MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 LEAD-LINED GLASS, DOORS, AND WINDOWS
    • 6.3.1 ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH
    • TABLE 16 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021-2028 (USD MILLION)
  • 6.4 LEAD-LINED DRYWALLS & PLYWOOD
    • 6.4.1 GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET
    • TABLE 17 MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021-2028 (USD MILLION)
  • 6.5 SHIELDS, BARRIERS, AND BOOTHS
    • 6.5.1 INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH
    • TABLE 18 MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021-2028 (USD MILLION)
  • 6.6 LEAD SHEETS
    • 6.6.1 CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND
    • TABLE 19 MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021-2028 (USD MILLION)
  • 6.7 LEAD BRICKS
    • 6.7.1 RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS
    • TABLE 20 MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021-2028 (USD MILLION)
  • 6.8 HIGH-DENSITY CONCRETE BLOCKS
    • 6.8.1 SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND
    • TABLE 21 MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021-2028 (USD MILLION)
  • 6.9 X-RAY ROOMS
    • 6.9.1 DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES
    • TABLE 22 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021-2028 (USD MILLION)
  • 6.10 LEAD CURTAINS & SCREENS
    • 6.10.1 GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH
    • TABLE 23 MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021-2028 (USD MILLION)
  • 6.11 LEAD ACRYLIC
    • 6.11.1 SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION
    • TABLE 24 MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021-2028 (USD MILLION)

7 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION

  • 7.1 INTRODUCTION
    • TABLE 25 MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
  • 7.2 RADIATION THERAPY SHIELDING
    • TABLE 26 RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 7.2.1 LINEAR ACCELERATORS
      • 7.2.1.1 Growing adoption of linear accelerators to drive market growth
    • TABLE 28 MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.2 MULTIMODALITY IMAGING
      • 7.2.2.1 Recent advances in multimodality imaging to boost market
    • TABLE 29 MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.3 CYCLOTRONS
      • 7.2.3.1 Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth
    • TABLE 30 MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.4 BRACHYTHERAPY
      • 7.2.4.1 Ability of brachytherapy to deliver low-dose radiation to drive market
    • TABLE 31 MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.5 PROTON THERAPY
      • 7.2.5.1 Non-invasive and non-threatening nature of proton therapy to fuel adoption
    • TABLE 32 MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 DIAGNOSTIC SHIELDING
    • TABLE 33 DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 7.3.1 CT SCANNERS
      • 7.3.1.1 Rising demand for CT systems from hospitals, clinics, and ASCs to drive market
    • TABLE 35 MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.2 X-RAY IMAGING
      • 7.3.2.1 Consistent high quality of images provided by digital imaging to boost demand
    • TABLE 36 MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.3 MRI
      • 7.3.3.1 Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth
    • TABLE 37 MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.4 NUCLEAR IMAGING
      • 7.3.4.1 Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally
    • TABLE 38 MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021-2028 (USD MILLION)

8 MEDICAL RADIATION SHIELDING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 39 MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS, ASCS, AND CLINICS
    • 8.2.1 INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH
    • TABLE 40 MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC CENTERS
    • 8.3.1 GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH
    • TABLE 41 MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)

9 MEDICAL RADIATION SHIELDING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 42 MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 24 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American medical radiation shielding market during forecast period
    • TABLE 49 US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 50 US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 51 US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Increasing number of radiography procedures to support market growth in Canada
    • TABLE 54 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 55 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 56 CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 58 CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 59 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 61 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 62 EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Growing geriatric population and increasing radiography procedures in Germany to favor market growth
    • TABLE 65 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 66 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 67 GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Large number of CT procedures performed to fuel market
    • TABLE 70 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 71 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 72 FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Increasing government initiatives and support to aid market
    • TABLE 75 UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 76 UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 77 UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 79 UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.5 REST OF EUROPE
    • TABLE 80 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 81 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 82 REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 25 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT
    • TABLE 85 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Large patient pool and rising healthcare spending to aid market
    • TABLE 91 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 92 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 93 CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising awareness about radiation exposure to drive market
    • TABLE 96 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 97 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 98 JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Favorable government policies and healthcare infrastructure to support market
    • TABLE 101 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 102 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 103 INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 106 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040
    • TABLE 107 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 108 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 109 REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 REST OF THE WORLD (ROW)
    • 9.5.1 REST OF THE WORLD (ROW): RECESSION IMPACT
    • TABLE 112 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET
  • 10.2 MARKET RANKING
    • TABLE 118 TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET
  • 10.3 COMPANY EVALUATION QUADRANT FOR TOP PLAYERS
    • 10.3.1 STARS
    • 10.3.2 EMERGING LEADERS
    • 10.3.3 PARTICIPANTS
    • 10.3.4 PERVASIVE PLAYERS
    • FIGURE 26 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
  • 10.4 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
    • 10.4.1 PROGRESSIVE COMPANIES
    • 10.4.2 STARTING BLOCKS
    • 10.4.3 RESPONSIVE COMPANIES
    • 10.4.4 DYNAMIC COMPANIES
    • FIGURE 27 MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
  • 10.5 COMPETITIVE BENCHMARKING
    • TABLE 119 MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 10.6 COMPANY FOOTPRINT ANALYSIS
    • TABLE 120 FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 121 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 122 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 DEALS
    • TABLE 123 KEY DEALS, JANUARY 2020-MAY 2023
    • 10.7.2 OTHER DEVELOPMENTS
    • TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020-MAY 2023

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business overview, Products offered, Recent Developments, MNM view)**
    • 11.1.1 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)
    • TABLE 125 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW
    • FIGURE 28 ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)
    • 11.1.2 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)
    • TABLE 126 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW
    • FIGURE 29 BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)
    • 11.1.3 NELCO WORLDWIDE
    • TABLE 127 NELCO WORLDWIDE: BUSINESS OVERVIEW
    • 11.1.4 GAVEN INDUSTRIES, INC.
    • TABLE 128 GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW
    • 11.1.5 RADIATION PROTECTION PRODUCTS, INC.
    • TABLE 129 RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW
    • 11.1.6 MARSHIELD (A DIVISION OF MARS METAL CO.)
    • TABLE 130 MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW
    • 11.1.7 RAY-BAR ENGINEERING CORP.
    • TABLE 131 RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW
    • 11.1.8 AMRAY MEDICAL
    • TABLE 132 AMRAY MEDICAL: BUSINESS OVERVIEW
    • 11.1.9 A&L SHIELDING
    • TABLE 133 A&L SHIELDING: BUSINESS OVERVIEW
    • 11.1.10 GLOBAL PARTNERS IN SHIELDING, INC.
    • TABLE 134 GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW
    • 11.1.11 VERITAS MEDICAL SOLUTIONS LLC
    • TABLE 135 VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW
    • 11.1.12 ALIMED, INC.
    • TABLE 136 ALIMED, INC.: BUSINESS OVERVIEW
    • 11.1.13 PROTECH MEDICAL
    • TABLE 137 PROTECH MEDICAL: BUSINESS OVERVIEW
    • 11.1.14 GLOBE COMPOSITE SOLUTIONS LLC
    • TABLE 138 GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW
    • 11.1.15 ULTRARAY
    • TABLE 139 ULTRARAY: BUSINESS OVERVIEW
    • 11.1.16 MARS METAL COMPANY
    • TABLE 140 MARS METAL COMPANY: BUSINESS OVERVIEW
    • 11.1.17 NUCLEAR LEAD CO.
    • TABLE 141 NUCLEAR LEAD CO.: BUSINESS OVERVIEW
    • 11.1.18 NUCLEAR SHIELDS B.V.
    • TABLE 142 NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW
  • *Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 SHIELDING INTERNATIONAL INC.
    • 11.2.2 BAR-RAY PRODUCTS, INC.
    • 11.2.3 XENA SHIELD
    • 11.2.4 BURLINGTON MEDICAL
    • 11.2.5 SIMAD SRL
    • 11.2.6 EUROPEAN EMC PRODUCTS

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS